NASDAQ:SMMT
Summit Therapeutics Inc.
- Stock
industry
Biotechnologyexchange
NASDAQ Global Marketwebsite
www.summittxinc.comipo date
Mar 04, 2015full time employees
76currency
USD
Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate is ridinilazole, an orally administered small molecule antibiot...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus